Blocking protein farnesyltransferase improves nuclear blebbing in mouse fibroblasts with a targeted Hutchinson–Gilford progeria syndrome mutation

Lignende værker

• A farnesyltransferase inhibitor improves disease phenotypes in mice with a Hutchinson-Gilford progeria syndrome mutation
  af: Yang, Shao H., et al.
  Udgivet: (2006)
• Treatment with a Farnesyltransferase Inhibitor Improves Survival in Mice with a Hutchinson-Gilford Progeria Syndrome Mutation
  af: Yang, Shao H., et al.
  Udgivet: (2007)
• Clinical trial of a farnesyltransferase inhibitor in children with Hutchinson–Gilford progeria syndrome
  af: Gordon, Leslie B., et al.
  Udgivet: (2012)
• Inhibiting farnesylation reverses the nuclear morphology defect in a HeLa cell model for Hutchinson-Gilford progeria syndrome
  af: Mallampalli, Monica P., et al.
  Udgivet: (2005)
• Intermittent treatment with farnesyltransferase inhibitor and sulforaphane improves cellular homeostasis in Hutchinson-Gilford progeria fibroblasts
  af: Gabriel, Diana, et al.
  Udgivet: (2017)